Vasay, Rene-will C.
HRN: 22-00-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/16/2025
10/23/2025
IV
4.5 G IV LD THEN 2.25G
Every 8 Hours
Periappendicial Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes